Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

2007629 citationsJournal Articlebronze Open Access

Authors

Mary Pinder · The University of Texas Medical Branch at Galveston

Zhigang Duan · The University of Texas MD Anderson Cancer Center

James S. Goodwin · The University of Texas MD Anderson Cancer Center

Gabriel N. Hortobágyi · The University of Texas Medical Branch at Galveston

Sharon H. Giordano · The University of Texas MD Anderson Cancer Center

Abstract

Women aged 66 to 70 years who received adjuvant anthracyclines had significantly higher rates of CHF. The difference in rates of CHF continued to increase through more than 10 years of follow-up.

Topics & Keywords

Chemotherapy-induced cardiotoxicity and mitigation Cancer Treatment and Pharmacology Cardiac Imaging and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 25, Issue 25, pp. 3808-3815

DOI: 10.1200/jco.2006.10.4976

Field-Weighted Citation Impact: 18.51